Nuvalent, Inc.
NUVLNASDAQHealthcare● Active
$88.49
$-2.46(-2.70%)
Market Cap$6.5B
P/E Ratio—
52W High$113.015
52W Low$71.13
Nuvalent, Inc. (NUVL) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
NUVL · earnings · updated Jun 8, 2026
Latest Earnings
Q2 FY2026Report Date: May 7, 2026EPS Actual
-$1.39
Est. -$1.35 · -3.0%
Revenue
—
Est. $0.00B
Fiscal Period
Q2 FY2026
FY ends December
Report Date
May 7, 2026
After Market Close
▼ Miss EPS
NUVL reports quarterly as a NASDAQ-listed Biotechnology company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Days Away
85
days
Expected Date
Sep 1, 2026
Fiscal Period
Q3 FY2026
Release Time
◌ Time TBD (Unconfirmed)EPS Est.
—
Days Away85
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.—
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| ◌ Q3 FY2026 | Aug 6, 2026 | -$1.44 | — | — | — | $0.00B | — |
| ▼ Q2 FY2026 | May 7, 2026 | -$1.35 | -$1.39 | -3.0% | — | $0.00B | — |
| ▲ Q1 FY2026 | Feb 26, 2026 | -$1.48 | -$1.29 | +12.8% | — | $0.01B | — |
| ▼ Q4 FY2025 | Oct 30, 2025 | -$1.39 | -$1.70 | -22.3% | — | — | — |
| ▼ Q3 FY2025 | Aug 7, 2025 | -$1.27 | -$1.31 | -3.1% | — | — | — |
| ▼ Q2 FY2025 | May 8, 2025 | -$1.14 | -$1.18 | -3.5% | — | — | — |
| — Q1 FY2025 | Feb 27, 2025 | -$1.04 | -$1.05 | -1.0% | — | — | — |
| ▼ Q4 FY2024 | Nov 12, 2024 | -$0.93 | -$1.28 | -37.0% | — | — | — |
Q3 FY2026
Aug 6, 2026
EPS Actual
—
EPS Est.
-$1.44
EPS Surpr.
—
Revenue
—
Q2 FY2026
May 7, 2026Miss
EPS Actual
-$1.39
EPS Est.
-$1.35
EPS Surpr.
-3.0%
Revenue
—
Q1 FY2026
Feb 26, 2026Beat
EPS Actual
-$1.29
EPS Est.
-$1.48
EPS Surpr.
+12.8%
Revenue
—
Q4 FY2025
Oct 30, 2025Miss
EPS Actual
-$1.70
EPS Est.
-$1.39
EPS Surpr.
-22.3%
Revenue
—
Q3 FY2025
Aug 7, 2025Miss
EPS Actual
-$1.31
EPS Est.
-$1.27
EPS Surpr.
-3.1%
Revenue
—
Q2 FY2025
May 8, 2025Miss
EPS Actual
-$1.18
EPS Est.
-$1.14
EPS Surpr.
-3.5%
Revenue
—
Q1 FY2025
Feb 27, 2025
EPS Actual
-$1.05
EPS Est.
-$1.04
EPS Surpr.
-1.0%
Revenue
—
Q4 FY2024
Nov 12, 2024Miss
EPS Actual
-$1.28
EPS Est.
-$0.93
EPS Surpr.
-37.0%
Revenue
—
Analyst Estimates
EPS Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2027 | $-2.12 | $-0.80 | $0.04 | 4 |
| Q3 FY2027 | $-2.92 | $-1.11 | $0.05 | 8 |
| Q2 FY2027 | $-3.32 | $-1.26 | $0.06 | 5 |
| Q1 FY2027 | $-2.57 | $-0.97 | $0.04 | 4 |
| Q4 FY2026 | $-3.68 | $-1.40 | $0.06 | 4 |
| Q3 FY2026 | $-1.55 | $-1.44 | $-1.25 | 11 |
Revenue Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2027 | $0.0B | $0.1B | $0.1B | 5 |
| Q3 FY2027 | $0.0B | $0.0B | $0.1B | 5 |
| Q2 FY2027 | $0.0B | $0.0B | $0.1B | 5 |
| Q1 FY2027 | $0.0B | $0.0B | $0.1B | 5 |
| Q4 FY2026 | $0.0B | $0.0B | $0.0B | 5 |
| Q3 FY2026 | $0.0B | $0.0B | $0.0B | 10 |
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| ▼ Q2 FY2026 | May 7, 2026 | -3.0% | $104.26 | $102.40 | -1.78% |
| ▲ Q1 FY2026 | Feb 26, 2026 | +12.8% | $104.53 | $103.93 | -0.57% |
| ▼ Q4 FY2025 | Oct 30, 2025 | -22.3% | $102.97 | $98.17 | -4.66% |
| ▼ Q3 FY2025 | Aug 7, 2025 | -3.1% | $77.23 | $72.16 | -6.56% |
| ▼ Q2 FY2025 | May 8, 2025 | -3.5% | $66.72 | $71.60 | +7.31% |
| ▲ Q1 FY2025 | Feb 27, 2025 | -1.0% | $77.04 | $74.91 | -2.76% |
| ▼ Q4 FY2024 | Nov 12, 2024 | -37.0% | $94.39 | $90.99 | -3.60% |
| ▼ Q3 FY2024 | Aug 8, 2024 | -15.8% | $67.44 | $70.24 | +4.15% |
Q2 FY2026-1.78%
Report Date
May 7, 2026
EPS Beat/Miss
-3.0%
Price Before
$104.26
Price After
$102.40
Q1 FY2026-0.57%
Report Date
Feb 26, 2026
EPS Beat/Miss
+12.8%
Price Before
$104.53
Price After
$103.93
Q4 FY2025-4.66%
Report Date
Oct 30, 2025
EPS Beat/Miss
-22.3%
Price Before
$102.97
Price After
$98.17
Q3 FY2025-6.56%
Report Date
Aug 7, 2025
EPS Beat/Miss
-3.1%
Price Before
$77.23
Price After
$72.16
Q2 FY2025+7.31%
Report Date
May 8, 2025
EPS Beat/Miss
-3.5%
Price Before
$66.72
Price After
$71.60
Q1 FY2025-2.76%
Report Date
Feb 27, 2025
EPS Beat/Miss
-1.0%
Price Before
$77.04
Price After
$74.91
Q4 FY2024-3.60%
Report Date
Nov 12, 2024
EPS Beat/Miss
-37.0%
Price Before
$94.39
Price After
$90.99
Q3 FY2024+4.15%
Report Date
Aug 8, 2024
EPS Beat/Miss
-15.8%
Price Before
$67.44
Price After
$70.24
Avg Beat Reaction-1.66%
Avg Miss Reaction-0.86%
Beat Rate2 / 8 quarters
Largest Move+7.31% (Q2 FY2025)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: NUVL ends December
Nuvalent, Inc. (NUVL) most recently reported earnings on May 7, 2026 for Q2 FY2026, posting EPS of $-1.39 — missing the analyst consensus of $-1.35 by -3.0%. The next NUVL earnings date is expected around September 1, 2026.
Each quarter, investors track NUVL earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. NUVL revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
NUVL's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
NUVL earnings · 5 questionsNuvalent, Inc.'s next earnings report is expected around September 1, 2026. NUVL typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; NUVL historically reports after market close (AMC).
NUVL earnings datewhen is NUVL earningsNUVL next earnings datewhen does NUVL report earningsNUVL earnings calendar
▸ Source: FMP · Nuvalent, Inc. SEC filings · US GAAP · Nuvalent, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 8, 2026